Previous 10 | Next 10 |
InMode Revises Full-Year 2023 Guidance PR Newswire YOKNEAM, Israel , Dec. 6, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it is revising its full-year 2023 guidance. ...
2023-12-06 05:40:00 ET Investing in small-cap stocks can come with some incredible upside. These are stocks that don't trade at high valuations, which means that if they're successful there can be a lot of room for their valuations to rise higher in the future. On the flip side, however, th...
2023-12-04 12:23:31 ET Summary InMode Ltd. is a company in the medical aesthetics space known for their cutting-edge, minimally invasive technologies (a description of each product they offer is in the analysis). The company's financial performance for Q3 2023 showed modest but si...
2023-12-02 08:10:00 ET Finding a stock with the growth potential necessary to make its share price go parabolic is tough. However, in reality, investing in such stocks -- provided you identify them -- gets even more difficult because most of these stocks already carry a premium valuation. ...
2023-11-29 05:29:26 ET Summary InMode exhibited financial resilience in Q3 2023, with a modest increase in revenue and a significant rise in international sales. The stock price has recently declined but is now consolidating at lower levels, indicating a potential bottoming out. ...
2023-11-27 14:00:00 ET Summary InMode Ltd. investors experienced a collapse in October 2023 as INMD fell to a three-year low. I assessed that buyers have returned in November, potentially helping INMD to form a pivotal long-term bottom. InMode's best-in-class profitability and...
2023-11-26 23:45:18 ET Summary InMode, known for laser technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve drive demand, but geopolitical and economic factors contribute to stock ...
2023-11-08 02:25:00 ET Summary LRT Capital is a fundamental investment hedge fund. Our sole aim in crafting our investment program is to maximize long-term investment returns. October was a challenging month for the investment strategy, with long holdings declining sharply due to ...
2023-11-07 04:52:04 ET Summary InMode Ltd's share price fell by 25% in October due to the Israel-Hamas conflicts and lowered revenue guidance. The company operates in a niche market between plastic surgery and laser procedures, giving it a competitive advantage. InMode is well...
2023-11-06 10:01:49 ET More on iShares U.S. Medical Devices ETF: IHI: Nibbling Again On Attractive Healthcare Sector Valuation The FDA Crash - Are Regulations Killing The Bull Case For Medical Devices And IHI? FDA forms advisory committee to regulate digital health ...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...